Anthony S. Fauci, MD returns to JAMA’s Q&A series to discuss the latest developments in the COVID-19 pandemic, including the continued importance of nonpharmaceutical interventions (masking, handwashing, physical distancing) for managing rising case numbers in the US and globally.
Recorded October 28, 2020.
Topics discussed in this interview: 0:00 Introduction 0:20 NAM Presidential Citation for Exemplary Leadership 1:19 COVID-19 numbers and excess deaths 4:05 National masking mandate 5:55 How to get people to accept masking 7:07 Herd Immunity and the Great Barrington Declaration 9:51 The holidays and airplane travel 13:44 Therapies update 17:54 Vaccines update 20:08 Vaccine distribution 22:00 Vaccine safety 24:42 How Australia has dealt with COVID-19 spikes 27:00 Acknowledgements and baseball
OvernightPresident Trump and First Lady Melania Trump announced that they have tested positive for the coronavirus. In a statement shortly thereafter, the White House physician said the Trumps “are both well at this time” and will remain at home.
The president is 74 years old, which generally puts him at higher risk for severe illness from the virus, according to CDC guidelines.
Plus, the latest on the stimulus bill
And, big tech has become a bipartisan punching bag.
Guests: Axios’ Sam Baker, Alayna Treene and Ashley Gold.
As government and private money pour into the global race for a Covid-19 vaccine, drugmakers are under great pressure to keep the shot affordable while also keeping investors happy. WSJ explains what this means for the final price tag of the jabs.
Ben Boudreaux, policy researcher with the RAND Corporation, describes how contact tracing can be used to track the spread of COVID-19 and explains the differences between manual and automated contact tracing.
WASHINGTON POST (AUG 16, 2020): Researchers in the United States set an audacious goal in January to develop a coronavirus vaccine within 12 to 18 months. This would be a world record. The mumps vaccine is considered to be the fastest to move, in four years, from scientific concept to approval in 1967. The quest for an HIV vaccine continues, 36 years and counting.